This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Should You Retain Brighthouse (BHF) Stock in Your Portfolio?
by Zacks Equity Research
Brighthouse (BHF) is well poised for growth on the back of higher underwriting margin, strong annuity sales, lower expenses and prudent capital deployment.
Reasons to Hold Trupanion (TRUP) Stock in Your Portfolio Now
by Zacks Equity Research
Trupanion (TRUP) is poised to grow on a change in the attitude of pet owners who are focusing on pets' health and well-being in an underpenetrated pet insurance market, product launches and extended operating boundaries.
Should You Retain EverQuote (EVER) Stock in Your Portfolio?
by Zacks Equity Research
EverQuote (EVER) is poised to benefit from higher quote requests, solid performance of automotive insurance providers and sufficient liquidity.
Why Is MetLife (MET) Down 0.7% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Insurance ETFs to Gain on Solid Q1 Earnings
by Sweta Killa
Take a look at insurance ETFs post Q1 earnings.
MetLife's (MET) Q1 Earnings Beat on Strong Latin America Unit
by Zacks Equity Research
MetLife's (MET) first-quarter earnings indicate higher premiums and a decline in expenses. A new share repurchase authorization worth $3 billion reflects MET's sound capital position.
MetLife (MET) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 27.61% and 3.52%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Insurance Stock Q1 Earnings List for May 4: MET, ALL, AFG, LNC
by Kaibalya Pravo Dey
Reopening of business activities throughout the first quarter is likely to have aided the insurance stock results, offset by a soft pricing environment. MET, ALL, AFG and LNC are set to report earnings performance on May 4.
MetLife (MET) Gears Up for Q1 Earnings: What to Expect?
by Zacks Equity Research
MetLife's (MET) first-quarter results are likely to reflect lower net investment income and escalating costs due to technology investments, partly offset by revenue growth stemming from higher premiums.
Analysts Estimate MetLife (MET) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MetLife's (MET) Arm MIM Closes $1.6B Private Equity Fund
by Zacks Equity Research
MetLife's (MET) business MIM used the secondaries market for third-party equity fund. The portfolio includes 80 fund positions across various sectors.
MetLife (MET) Arm Gets CBI License to Aid European Investors
by Zacks Equity Research
MetLife's (MET) institutional asset management business MIM receives a CBI authorization, which in turn, will help it deliver sound investment capabilities and benefit investors in the EEA.
Zacks Industry Outlook Highlights MetLife, American International Group, The Hartford Financial Services Group, Old Republic International, and Horace Mann Educators
by Zacks Equity Research
MetLife, American International Group, The Hartford Financial Services Group, Old Republic International, and Horace Mann Educators are part of today's industry outlook article.
5 Multiline Insurers to Watch as Pandemic Impact Recedes
by Tanuka De
Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, HIG, ORI and HMN as the impact of the pandemic recedes.
MetLife (MET) Unit Hits Milestone in Agricultural Mortgage Loans
by Zacks Equity Research
MetLife (MET) business unit MetLife Investment Management (MIM) creates a record by originating $6 billion in agricultural mortgage loans during 2021.
MetLife (MET) Ties Up to Offer Better Pet Care With New Program
by Zacks Equity Research
MetLife (MET) collaborates with LifeBalance for launching MyPets rewards program in a bid to offer pet parents substantial savings while purchasing pet care commodities.
MetLife's (MET) Structured Solution to Offer Financial Security
by Zacks Equity Research
MetLife (MET) launches a Structured Installment Sale solution with an aim to offer a guaranteed periodic income and defer tax liability of the sellers of qualified properties.
Why Is MetLife (MET) Down 1.7% Since Last Earnings Report?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MetLife (MET) Offers Employers Aura's Digital Security Solutions
by Zacks Equity Research
MetLife (MET) forges an alliance with Aura to safeguard the digital identity of employees, having access to its U.S. Group Benefits platform, with the latter's solutions.
Owl Rock Capital (ORCC) Q4 Earnings Beat Mark, Jump Y/Y
by Zacks Equity Research
Owl Rock Capital's (ORCC) fourth-quarter results are supported by an increase in the debt investment portfolio.
AMERISAFE (AMSF) Earnings Break Even in Q4, Revenues Lag
by Zacks Equity Research
AMERISAFE's (AMSF) fourth-quarter results hurt by fall in revenues, soft underwriting results and increasing expenses.
Insurance ETFs to Rally on Solid Q4 Earnings
by Sweta Killa
Some of the prominent players in the insurance industry surpassed estimates for both earnings and revenues.
Top Analyst Reports for Alphabet, Texas Instruments & Linde
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Texas Instruments Incorporated (TXN), and Linde plc (LIN).
MetLife (MET) Extends Solution to Aid Bangladesh Consumers
by Zacks Equity Research
MetLife (MET) launches its cutting-edge 360Health solution in Bangladesh with an aim to empower the country's customers to effectively tackle critical illnesses.